These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23881789)

  • 1. CXCR4 antagonism attenuates load-induced periosteal bone formation in mice.
    Leucht P; Temiyasathit S; Russell A; Arguello JF; Jacobs CR; Helms JA; Castillo AB
    J Orthop Res; 2013 Nov; 31(11):1828-38. PubMed ID: 23881789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SDF-1/Cxcr4 Signaling Antagonist AMD3100 on Bone Mineralization in Distraction Osteogenesis.
    Xu J; Chen Y; Liu Y; Zhang J; Kang Q; Ho K; Chai Y; Li G
    Calcif Tissue Int; 2017 Jun; 100(6):641-652. PubMed ID: 28303319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
    Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
    Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart.
    Cheng M; Huang K; Zhou J; Yan D; Tang YL; Zhao TC; Miller RJ; Kishore R; Losordo DW; Qin G
    J Mol Cell Cardiol; 2015 Apr; 81():49-53. PubMed ID: 25655934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition.
    Liu X; Zhou C; Li Y; Ji Y; Xu G; Wang X; Yan J
    PLoS One; 2013; 8(1):e54077. PubMed ID: 23349789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
    Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
    Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity.
    Cheng M; Zhou J; Wu M; Boriboun C; Thorne T; Liu T; Xiang Z; Zeng Q; Tanaka T; Tang YL; Kishore R; Tomasson MH; Miller RJ; Losordo DW; Qin G
    Circ Res; 2010 Oct; 107(9):1083-93. PubMed ID: 20847314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model.
    Wang X; Wang C; Gou W; Xu X; Wang Y; Wang A; Xu W; Guo Q; Liu S; Lu Q; Meng H; Yuan M; Peng J; Lu S
    Stem Cell Res Ther; 2018 Oct; 9(1):272. PubMed ID: 30359311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells regulate mechanical properties of human degenerated nucleus pulposus cells through SDF-1/CXCR4/AKT axis.
    Liu MH; Bian BS; Cui X; Liu LT; Liu H; Huang B; Cui YH; Bian XW; Zhou Y
    Biochim Biophys Acta; 2016 Aug; 1863(8):1961-8. PubMed ID: 27163878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair.
    Toupadakis CA; Wong A; Genetos DC; Chung DJ; Murugesh D; Anderson MJ; Loots GG; Christiansen BA; Kapatkin AS; Yellowley CE
    J Orthop Res; 2012 Nov; 30(11):1853-9. PubMed ID: 22592891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 positive bone mesenchymal stem cells migrate to human endothelial cell stimulated by ox-LDL via SDF-1alpha/CXCR4 signaling axis.
    Li M; Yu J; Li Y; Li D; Yan D; Qu Z; Ruan Q
    Exp Mol Pathol; 2010 Apr; 88(2):250-5. PubMed ID: 20025867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system.
    Shiba Y; Takahashi M; Yoshioka T; Yajima N; Morimoto H; Izawa A; Ise H; Hatake K; Motoyoshi K; Ikeda U
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):283-9. PubMed ID: 17053169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
    Zhu WB; Zhao ZF; Zhou X
    J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.
    Alsayed Y; Ngo H; Runnels J; Leleu X; Singha UK; Pitsillides CM; Spencer JA; Kimlinger T; Ghobrial JM; Jia X; Lu G; Timm M; Kumar A; Côté D; Veilleux I; Hedin KE; Roodman GD; Witzig TE; Kung AL; Hideshima T; Anderson KC; Lin CP; Ghobrial IM
    Blood; 2007 Apr; 109(7):2708-17. PubMed ID: 17119115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
    Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N
    Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low intensity pulsed ultrasound enhanced mesenchymal stem cell recruitment through stromal derived factor-1 signaling in fracture healing.
    Wei FY; Leung KS; Li G; Qin J; Chow SK; Huang S; Sun MH; Qin L; Cheung WH
    PLoS One; 2014; 9(9):e106722. PubMed ID: 25181476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
    Kawaguchi A; Orba Y; Kimura T; Iha H; Ogata M; Tsuji T; Ainai A; Sata T; Okamoto T; Hall WW; Sawa H; Hasegawa H
    Blood; 2009 Oct; 114(14):2961-8. PubMed ID: 19657116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation.
    Wise JK; Sumner DR; Virdi AS
    Tissue Eng Part A; 2012 Apr; 18(7-8):860-9. PubMed ID: 22035136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.